Analytical and biological methods for probing the blood-brain barrier

Annual Review of Analytical Chemistry

Volumn 5, Issue , 2012, Pages 505-531

  Kuhnline Sloan, Courtney D ^a   Nandi, Pradyot ^a   Linz, Thomas H ^a   Aldrich, Jane V ^a   Audus, Kenneth L ^a   Lunte, Susan M ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

brain microvessel endothelial cell culture; drug analysis; microdialysis; microfluidics; peptides

Indexed keywords

ANALYTICAL METHOD; BIOLOGICAL METHODS; BLOOD-BRAIN BARRIER; BRAIN PERFUSION; CENTRAL NERVOUS SYSTEMS; DRUG ANALYSIS; ENDOGENOUS COMPOUND; ENDOGENOUS SUBSTANCES; EXTRACELLULAR FLUID; HARMFUL SUBSTANCES; IN-VITRO; IN-VIVO; INTRAVENOUS INJECTIONS; MICRO-DIALYSIS; MICRODIALYSIS SAMPLING;

CELL CULTURE; DIALYSIS; ENDOTHELIAL CELLS; METABOLISM; MICROFLUIDICS; PEPTIDES; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY;

BLOOD;

ANIMAL; BLOOD BRAIN BARRIER; BRAIN; CAPILLARY ELECTROPHORESIS; CULTURE TECHNIQUE; EQUIPMENT DESIGN; HUMAN; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MICRODIALYSIS; MICROFLUIDIC ANALYSIS; PERFUSION; POSITRON EMISSION TOMOGRAPHY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CELL CULTURE TECHNIQUES; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, CAPILLARY; EQUIPMENT DESIGN; HUMANS; INJECTIONS, INTRAVENOUS; MASS SPECTROMETRY; MICRODIALYSIS; MICROFLUIDIC ANALYTICAL TECHNIQUES; PERFUSION; POSITRON-EMISSION TOMOGRAPHY;

EID: 84863334894     PISSN: 19361327     EISSN: 19361335     Source Type: Book Series    
DOI: 10.1146/annurev-anchem-062011-143002     Document Type: Review

References (122)

1. Cardoso FL, Brites D, Brito MA. 2010. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res. Rev. 64:328-63
2. Abbott NJ, Roennbaeck L, Hansson E. 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7:41-53 (Pubitemid 41828930)
3. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. 2010. Structure and function of the blood-brain barrier. Neurobiol. Dis. 37:13-25
4. Jain AJ, SK. 2011. Drug targeting to brain: a review. Curr. Nanosci. 7:21-36
5. Jeffrey P, Summerfield S. 2010. Assessment of the blood-brain barrier in CNS drug discovery. Neurobiol. Dis. 37:33-37
6. Vangilder RL, Rosen CL, Barr TL, Huber JD. 2011. Targeting the neurovascular unit for treatment of neurological disorders. Pharmacol. Ther. 130:239-47
7. Lok J, Gupta P, Guo S, KimWJ, Whalen MJ, et al. 2007. Cell-cell signaling in the neurovascular unit. Neurochem. Res. 32:2032-45 (Pubitemid 350059847)
8. Ransohoff RM, Perry VH. 2009. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27:119-45
9. Mangas-Sanjuan V, Gonzalez-Alvarez M, Gonzalez-Alverez I, Bermejo M. 2010. Drug penetration across the blood-brain barrier: an overview. Ther. Deliv. 1:535-62
10. Nag S, Kapadia A, Stewart DJ. 2011. Review: molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol. Appl. Neurobiol. 37:3-23
11. Abbott NJ, Dolman DEM, Patabendige AK. 2008. Assays to predict drug permeation across the bloodbrain barrier, and distribution to brain. Curr. Drug Metab. 9:901-10
12. Bentivoglio M, Mariotti R, Bertini G. 2011. Neuroinflammation and brain infections: historical context and current perspectives. Brain Res. Rev. 66:152-73
13. Westerhout J, Danhof M, De Lange EC. 2011. Preclinical prediction of human brain target site concentrations: considerations in extrapolating to the clinical setting. J. Pharm. Sci. 100:3577-93
14. Hammarlund-UdenaesM, Bredberg U, Fridén M. 2009. Methodologies to assess brain drug delivery in lead optimization. Curr. Top. Med. Chem. 9:148-62
15. Nicolazzo JA, Charman SA, CharmanWN. 2006. Methods to assess drug permeability across the bloodbrain barrier. J. Pharm. Pharmacol. 58:281-93 (Pubitemid 43344570)
16. Smith Q. 2003. A review of blood-brain barrier transport techniques. In The Blood-Brain Barrier: Biology and Research Protocols, ed. S Nag, pp. 193-207. Totowa, NJ: Humana
17. Smith QR, Allan DD. 2003. In situ brain perfusion technique. In The Blood-Brain Barrier: Biology and Research Protocols, ed. S Nag, pp. 209-18. Totowa, NJ: Humana
18. Takasato Y, Rapoport SI, SmithQR. 1984. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. Heart Circ. Physiol. 247:484-93
19. Miller JM, Kumar D, Mann JJ, Parsey RV. 2008. Applications of positron emission tomography in neuropsychiatric pharmaceutical drug development. Curr. Radiopharm. 1:12-16
20. Pike VW. 2009. PET radiotracers: crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol. Sci. 30:431-40
21. Syvanenl S, Hammarlund-Udenaes M. 2010. Using PET studies of P-gp function to elucidate mechanisms underlying the disposition of drugs. Curr. Top. Med. Chem. 10:1799-809
22. Josserand V, Pelerin H, de Bruin B, Jego B, Kuhnast B, et al. 2006. Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier. J. Pharmacol. Exp. Ther. 316:79-86 (Pubitemid 41832583)
23. Delgado JM, Defeudis FV, Roth RH, Ryugo DK, Mitruka BM. 1972. Dialytrode for long term intracerebral perfusion in awake monkeys. Arch. Int. Pharm. Ther. 198:9-21
24. Ungerstedt U. 1991. Introduction to intracerebral microdialysis. In Microdialysis in the Neurosciences, ed. TE Robinson, JB Justice Jr., pp. 3-22. Amsterdam: Elsevier
25. Westerink BHC, Cremers TIFH. 2007. Handbook of Microdialysis. Amsterdam: Elsevier. 697 p.p.
26. de Lange EC. 2007. Microdialysis as a method to study blood brain barrier transport mechanisms. In Handbook of Microdialysis, ed. BHCWesterink, TIFH Cremers, pp. 545-72. Amsterdam: Elsevier
27. Chaurasia CS, Müller M, Bashaw ED, Benfeldt E, Bolinder J, et al. 2007. AAPS-FDAWorkshop white paper: microdialysis principles, application and regulatory perspectives. Pharm. Res. 24:1014-25 (Pubitemid 46675390)
28. Telting-Diaz M, Scott DO, Lunte CE. 1992. Intravenous microdialysis sampling in awake, freelymoving rats. Anal. Chem. 64:806-10
29. Woods JE II, Cadle K, Solomon B, Gunaratna C, Duda C, Kissinger C. 2006. Simultaneous determination of nicotine and cotinine pharmacokinetics in the blood and brain using a combination of automated blood sampling and in vivo microdialysis in Sprague Dawley rats. Curr. Sep. Drug Dev. 21:85-90
30. Huff JK, Davies MI. 2002. Microdialysis monitoring of methylphenidate in blood and brain correlated with changes in dopamine and rat activity. J. Pharm. Biomed. Anal. 29:767-77 (Pubitemid 34692592)
31. de Lange ECM, de Vries JD, Zurcher C, Danhof M, de Boer AG, Breimer DD. 1995. The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain. Pharm. Res. 12:1924-31 (Pubitemid 26031779)
32. de Lange ECM, de Boer AG, Breimer DD. 1999. Microdialysis for pharmacokinetic analysis of drug transport to the brain. Adv. Drug Deliv. Rev. 36:211-27 (Pubitemid 29121973)
33. Freed AL, Audus KL, Lunte SM. 2001. Investigation of the metabolism of substance P at the bloodbrain barrier using capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 22:3778-84
34. Kostel KL, Lunte SM. 1997. Evaluation of capillary electrophoresis with post-column derivatization and laser-induced fluorescence detection for the determination of substance P and its metabolites. J. Chromatogr. B 695:27-38 (Pubitemid 27308602)
35. Reed B, Bidlack JM, Chait BT, Kreek MJ. 2008. Extracellular biotransformation of beta-endorphin in rat striatum and cerebrospinal fluid. J. Neuroendocrinol. 20:606-16 (Pubitemid 351541453)
36. de Lange ECM, Danhof M, de Boer AG, Breimer DD. 1997. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier. Brain Res. Rev. 25:27-49 (Pubitemid 27459719)
37. Brunner M, Derendorf H. 2006. Clinical microdialysis: current applications and potential use in drug development. Trends Anal. Chem. 25:674-80 (Pubitemid 44093742)
38. GrabbMC, SciottiVM,Gidday JM,Cohen SA, van WylenDG.1998. Neurochemical andmorphological responses to acutely and chronically implanted brain microdialysis probes. J. Neurosci.Methods 82:25-34 (Pubitemid 28335469)
39. Benveniste H, Drejer J, Schousboe A, Diemer NH. 1987. Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat. J. Neurochem. 49:729-34
40. Jaquins-Gerstl A,Michael AC. 2009. Comparison of the brain penetration injury associated with microdialysis and voltammetry. J. Neurosci. Methods 183:127-35
41. Jaquins-Gerstl A, Shu Z, Zhang J, Liu Y, Weber SG, Michael AC. 2011. Effect of dexamethasone on gliosis, ischemia, and dopamine extraction during microdialysis sampling in brain tissue. Anal. Chem. 83:7662-67
42. de Lange EC, DanhofM, de Boer AG, Breimer DD. 1994. Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain. Brain Res. 666:1-8 (Pubitemid 24359646)
43. Choi YH, Fletcher PJ, Wong CCS, Andersen GH. 1999. Measurement of blood brain permeability in rats with α amino butyric acid during microdialysis: application to behavioral studies. Physiol. Behav. 67:587-98 (Pubitemid 29488539)
44. Major O, Shdanova T, Duffek L, Nagy Z. 1990. Continuous monitoring of blood-brain barrier opening to Cr51-EDTA by microdialysis following probe injury. Acta Neurochir. Suppl. 51:46-48
45. Hascup ER, af Bjerkén S, Hascup KN, Pomerleau F, Huettl P, et al. 2009. Histological studies of the effects of chronic implantation of ceramic-based microelectrode arrays and microdialysis probes in rat prefrontal cortex. Brain Res. 1291:12-20
46. Stenken JA. 1999. Methods and issues in microdialysis calibration. Anal. Chim. Acta 379:337-57
47. Bungay PM,Morrison PF, Dedrick RL, Chefer VI, Zapata A. 2006. Chapter 2.2: Principles of quantitative microdialysis. In Handbook of Behavioral Neuroscience, ed. BHCWesterink, TIFH Cremers, pp. 131- 67. Amsterdam: Elsevier
48. Lonnroth P, Jansson PA, Smith U. 1987. A microdialysis method allowing characterization of intercellular water space in humans. Am. J. Physiol. Endocrinol. Metab. 253:228-31
49. Kehr J. 1993. A survey on quantitative microdialysis: theoretical models and practical implications. J. Neurosci. Methods 48:251-61 (Pubitemid 23244114)
50. Song Y, Lunte CE. 1999. Comparison of calibration by delivery versus no net flux for quantitative in vivo microdialysis sampling. Anal. Chim. Acta 379:251-62 (Pubitemid 29046456)
51. Wang Y, Wong SL, Sawchuk RJ. 1993. Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus. Pharm. Res. 10:1411-19 (Pubitemid 23302655)
52. Dai H, Elmquist W. 2003. Drug transport studies using quantitative microdialysis. In The Blood-Brain Barrier: Biology and Research Protocols, ed. S Nag, pp. 249-64. Totowa, NJ: Humana
53. Bengtsson J, Bostroem E,Hammarlund-UdenaesM. 2008. The use of a deuterated calibrator for in vivo recovery estimations in microdialysis studies. J. Pharm. Sci. 97:3433-41
54. Menacherry S, Hubert W, Justice JB Jr. 1992. In vivo calibration of microdialysis probes for exogenous compounds. Anal. Chem. 64:577-83
55. Kennedy RT, Watson CJ, Haskins WE, Powell DH, Strecker RE. 2002. In vivo neurochemical monitoring by microdialysis and capillary separations. Curr. Opin. Chem. Biol. 6:659-65 (Pubitemid 35284198)
56. Nandi P, Lunte SM. 2009. Recent trends in microdialysis sampling integrated with conventional and microanalytical systems for monitoring biological events: a review. Anal. Chim. Acta 651:1-14
57. Cremers TIFH, de Vries MG, Huinink KD, van Loon JP, Hart MVD, et al. 2009. Quantitative microdialysis using modified ultraslow microdialysis: direct rapid and reliable determination of free brain concentrations with the MetaQuant technique. J. Neurosci. Methods 178:249-54
58. Hammarlund-Udenaes M. 2010. Active-site concentrations of chemicals: Are they a better predictor of effect than plasma/organ/tissue concentrations? Basic Clin. Pharmacol. Toxicol. 106:215-20
59. Nandi P, Lunte SM. 2010. Microdialysis sampling as a sample preparationmethod. In Handbook of Sample Preparation, ed. J Pawliszyn, HL Lord, pp. 103-24. Hoboken:Wiley
60. Telting-Diaz M, Lunte CE. 1993. Distribution of tacrine across the blood-brain barrier in awake, freely moving rats using in vivo microdialysis sampling. Pharm. Res. 10:44-48 (Pubitemid 23020836)
61. Crick EW, Osorio I, Bhavaraju NC, Linz TH, Lunte CE. 2007. An investigation into the pharmacokinetics of 3-mercaptopropionic acid and development of a steady-state chemical seizure model using in vivo microdialysis and electrophysiological monitoring. Epilepsy Res. 74:116-25 (Pubitemid 46654740)
62. Weiss DJ, Krisko RM, Lunte CE. 2002. Applications of microdialysis/mass spectrometry to drug discovery. In Mass Spectrometry in Drug Discovery, ed. DT Rossi,MWSinz, pp. 377-97. New York: Marcel Dekker
63. Chappa AK, Cooper JD, Audus KL, Lunte SM. 2007. Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS/MS. J. Pharm. Biomed. Anal. 43:1409-15 (Pubitemid 46282358)
64. Cooper JD, Heppert KE, DaviesMI, Lunte SM. 2007. Evaluation of an osmotic pump for microdialysis sampling in an awake and untethered rat. J. Neurosci. Methods 160:269-75
65. Malone ML, Zuo H, Smyth MR, Lunte SM. 1995. Determination of tryptophan and kynurenine in brain microdialysis samples by capillary electrophoresis with electrochemical detection. J. Chromatogr. A 700:73-80
66. Kaul S, Faiman MD, Lunte CE. 2011. Determination of GABA, glutamate and carbamathione in brain microdialysis samples by capillary electrophoresis with fluorescence detection. Electrophoresis 32:284-91
67. Kaul S, FaimanMD,Lunte CE. 2011. Determination of GABA, glutamate, dopamine and carbamathione in brain microdialysis samples by micellar electrokinetic chromatography and laser-induced fluorescence (MEKC-LIF). Anal. Methods 3:1514-20
68. Nandi P, Desai DP, Lunte SM. 2010. Development of a PDMS-based microchip electrophoresis device for continuous online in vivo monitoring of microdialysis samples. Electrophoresis 31:1414-22
69. Janle EM, Lila MA, Grannan M, Wood L, Higgins A, et al. 2010. Method for evaluating the potential of 14C-labeled plant polyphenols to cross the blood-brain barrier using accelerator mass spectrometry. Nucl. Instrum. Methods B 268:1313-16
70. Sadiq MW, Salehpour M, Forsgard N, Possnert G, Hammarlund-Udenaes M. 2011. Morphine brain pharmacokinetics at very low concentrations studied with accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. 39:174-79
71. Audus KL, Borchardt RT. 1986. Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharm. Res. 3:81-87 (Pubitemid 17191154)
72. Spatz M, Mrsulja BB. 1982. Progress in cerebral microvascular studies related to the function of the blood-brain barrier. Adv. Cell. Neurobiol. 3:311-37
73. Thompson SE, Audus KL. 1993. Leucine-enkephalin metabolism in brain microvessel endothelial cells. Peptides 15:109-16
74. Baranczyk-Kuzma A, Audus KL, Borchardt RT. 1986. Catecholamine- metabolizing enzymes of bovine brain microvessel endothelial cell monolayers. J. Neurochem. 46:1956-60 (Pubitemid 16095507)
75. GumbletonM, Audus KL. 2001. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J. Pharm. Sci. 90:1681-98 (Pubitemid 33062590)
76. Desino KE. 2008. Improving blood-brain barrier permeation of small molecules exhibiting chemotherapeutic and neuroprotective effects. PhD thesis, Univ. Kans
77. Turunen BJ, Ge H, Oyetunji J, Desino KE, Vasandani V, et al. 2008. Paclitaxel succinate analogs: anionic and amide introduction as a strategy to impart blood-brain barrier permeability. Bioorg.Med. Chem. Lett. 18:5971-74
78. Yazdanian M, Bormann BJ. 2000. Immortalized brain endothelial cells. U.S. Patent 6,093,553
79. Wang Q, Rager JD, Weinstein K, Kardos PS, Dobson GL, et al. 2005. Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier. Int. J. Pharm. 288:349-59 (Pubitemid 40038588)
80. de Boer AG, Gaillard PJ. 2002. In vitro models of the blood-brain barrier: when to use which? Curr. Med. Chem. 2:203-9 (Pubitemid 36267725)
81. Reinhardt CA, Gloor SM. 1997. Co-culture blood-brain barrier models and their use for pharmatoxicological screening. Toxicol. In Vitro 11:513-18 (Pubitemid 27512694)
82. Takakura T, Audus KL, Borchardt RT. 1992. Cultured brain microvessel endothelial cells as in vitro models of the blood-brain barrier. NIDA Res. Monogr. 120:138-49
83. Sloan CDK. 2011. The development of analytical methods for investigations of dynorphin A 1-17 metabolism in the central nervous system and peripheral tissues and transport at the blood brain barrier. PhD thesis, Univ. Kans
84. Audus KL, Borchardt RT. 1986. Characteristics of the large neutral amino acid transport system of bovine brain microvessel endothelial cell monolayers. J. Neurochem. 47:484-88 (Pubitemid 16052866)
85. ShahMV, Audus KL, Borchardt RT. 1989. The application of bovine brain microvessel endothelial-cell monolayers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier. Pharm. Res. 6:624-27 (Pubitemid 19214429)
86. Freed AL, Audus KL, Lunte SM. 2002. Investigation of substance P transport across the blood-brain barrier. Peptides 23:157-65 (Pubitemid 34113776)
87. Chappa AK, Audus KL, Lunte SM. 2006. Characteristics of substance P transport across the blood-brain barrier. Pharm. Res. 23:1201-8 (Pubitemid 43946142)
88. Cooper J. 2003. Investigation of substance P metabolism and transport by liquid chromatography with tandem mass spectrometric detection. PhD thesis, Univ. Kans
89. Patkar KA,Murray TF, Aldrich JV. 2009. The effects of C-terminal modifications on the opioid activity of [N-benzylTyr1]dynorphin A-(1-11) analogues. J. Med. Chem. 52:6814-21
90. Chappa AK. 2007. Biopharmaceutical aspects of the development of peptides as CNS drug delivery vectors and therapeutic agents: studies with substance P and dynorphin analogs. PhD thesis, Univ. Kans.
91. Desino KE, Pignatello R, Guccione S, Basile L, Ansar S, et al. 2009. TCP-FA4: a derivative of tranylcypromine showing improved blood-brain permeability. Biochem. Pharmacol. 78:1412-17
92. Spence DM. 2008. Microfluidic technology as a platform to investigate microcirculation. In Handbook of Capillary and Microchip Electrophoresis and Associated Microtechniques, ed. JP Landers, pp. 841-52. Boca Raton: CRC
93. SandersGHW,Manz A. 2000. The incredibly shrinking laboratory reactions, separations and detections. J. Assoc. Lab. Autom. 5:40-45
94. Datta S, Ghosal S. 2009. Characterizing dispersion in microfluidic channels. Lab Chip 9:2537-50
95. Roman GT, Kennedy RT. 2007. Fully integrated microfluidic separations systems for biochemical analysis. J. Chromatogr. A 1168:170-88 (Pubitemid 47488325)
96. Bennet D, Kim S. 2011. Implantable microdevice for peripheral nerve regeneration: materials and fabrications. J. Mater. Sci. 46:4723-40
97. Gauvin R, Khademhosseini A. 2011. Microscale technologies and modular approaches for tissue engineering: moving toward the fabrication of complex functional structures. Am. Chem. Soc. Nano 5:4258-64
98. Martin RS, Root PD, Spence DM. 2006. Microfluidic technologies as platforms for performing quantitative cellular analyses in an in vitro environment. Analyst 131:1197-206 (Pubitemid 44655360)
99. Thiel VE, Audus KL. 2001. Nitric oxide and blood-brain barrier integrity. Antioxid. Redox Signal. 3:273-78 (Pubitemid 32473342)
100. Spence DM, Torrence NJ, Kovarik ML, Martin RS. 2004. Amperometric determination of nitric oxide derived from pulmonary artery endothelial cells immobilized in a microchip channel. Analyst 129:995-1000 (Pubitemid 39536454)
101. Hulvey MK, Martin RS. 2009. A microchip-based endothelium mimic utilizing open reservoirs for cell immobilization and integrated carbon ink microelectrodes for detection. Anal. Bioanal. Chem. 393:599-605 (Pubitemid 50325880)
102. Halpin ST, Spence DM. 2010. Direct plate-reader measurement of nitric oxide released from hypoxic erythrocytes flowing through a microfluidic device. Anal. Chem. 82:7492-97
103. Vogel PA, Halpin ST, Martin RS, Spence DM. 2011. Microfluidic transendothelial electrical resistance measurement device that enables blood flow and postgrowth experiments. Anal. Chem. 83:4296-301
104. Shao J, Wu L, Wu J, Zheng Y, Zhao H, et al. 2010. A microfluidic chip for permeability assays of endothelial monolayer. Biomed. Microdevices 12:81-88
105. Li MW, Martin RS. 2008. Microchip-based integration of cell immobilization, electrophoresis, postcolumn derivatization, and fluorescence detection for monitoring the release of dopamine from PC 12 cells. Analyst 133:1358-66
106. Li Z, Cui Z. 2008. Application ofmicrodialysis in tissue engineeringmonitoring. Progr. Nat. Sci. 18:503-11
107. Lunte SM, Nandi P, Regel A, Grigsby R, Hulvey MK, Scott D. 2010. The development of a miniaturized wireless microdialysis-microchip electrophoresis system for in vivo monitoring of drugs and neurotransmitters in awake and freely moving sheep. Presented at Int. Conf. Miniat. Syst. Chem. Life Sci., MicroTAS, 14th, Groningen, Neth.
108. Ueda Y, Doi T, Takaki M, Nagatomo K, Nakajima A, Willmore LJ. 2009. Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy. Brain Res. 1266:1-7
109. Andren PE,Emmett MR,DaGue BB, SteuletA-F,Waldmeier P,CaprioliRM. 1998. Blood-brain barrier penetration of 3-aminopropyl-n-butylphosphinic acid (CGP 36742) in rat brain by microdialysis/mass spectrometry. J. Mass Spectrom. 33:281-87 (Pubitemid 28144340)
110. Groenendaal D, Blom-RoosemalenMCM, DanhofM, de Lange ECM. 2005. High-performance liquid chromatography of nalbuphine, butorphanol and morphine in blood and brain microdialyzate samples: application to pharmacokinetic/ pharmacodynamic studies in rats. J. Chromatogr. B 822:230-37 (Pubitemid 40994056)
111. Zhang J, Qu F-R, Nakatsuka A, Nomura T, Nagai M, Nomoto M. 2003. Pharmacokinetics of L-DOPA in plasma and extracellular fluid of striatum in common marmosets. Brain Res. 993:54-58 (Pubitemid 37464582)
112. Sun Y, Nakashima MN, Takahashi M, Kuroda N, Nakashima K. 2002. Determination of bisphenol A in rat brain by microdialysis and column switching high-performance liquid chromatography with fluorescence detection. Biomed. Chromatogr. 16:319-26 (Pubitemid 34982343)
113. Sheu WHH, Chuang H-C, Cheng S-M, Lee M-R, Chou C-C, Cheng F-C. 2011. Microdialysis combined blood sampling technique for the determination of rosiglitazone and glucose in brain and blood of gerbils subjected to cerebral ischemia. J. Pharm. Biomed. Anal. 54:759-64
114. Blakeley JO, Olson J, Grossman SA, He X, Weingart J, Supko JG. 2009. Effect of blood-brain barrier permeability in recurrent high-grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study. J. Neuro-Oncol. 91:51-58
115. Kaul S, Williams TD, Lunte CE, Faiman MD. 2010. LC-MS/MS determination of carbamathione in microdialysis samples from rat brain and plasma. J. Pharm. Biomed. Anal. 51:186-91
116. Song Y, Xu J, Hamme A, Liu Y-M. 2006. Capillary liquid chromatography-tandemmass spectrometry of tetrahydroisoquinoline derived neurotoxins: a study on the blood-brain barrier of rat brain. J. Chromatogr. A 1103:229-34 (Pubitemid 43069402)
117. Chen KC. 2005. Evidence on extracellular dopamine level in rat striatum: implications for the validity of quantitative microdialysis. J. Neurochem. 92:46-58 (Pubitemid 40193508)
118. Whitaker G, Lunte CE. 2010. Investigation of microdialysis sampling calibration approaches for lipophilic analytes: doxorubicin. J. Pharm. Biomed. Anal. 53:490-96
119. Lin LC, Chen YF, Tsai TH. 2007. Analysis of brain distribution and biliary excretion of a nutrient supplement, gastrodin, in rat. Anal. Chim. Acta 590:173-79
120. Lin LC, Tsai TH. 2006. Pharmacokinetics and brain distribution of unbound levamisole in the anesthetized rats using microdialysis and microbore column liquid chromatography. Anal. Chim. Acta 569:145-50
121. Huang YJ, Liao JF, Tsai TH. 2005. Concurrent determination of thalidomide in rat blood, brain and bile using multiple microdialysis coupled to liquid chromatography. Biomed. Chromatogr. 19:488-93
122. Yang CS, Chang CH, Tsai PJ, Chen WY, Tseng FG, Lo LW. 2004. Nanoparticle-based in vivo investigation on blood-brain barrier permeability following ischemia and reperfusion. Anal. Chem. 76:4465-71 www.annualreviews.